Latest News

The National Institute for Health and Care Excellence (NICE) has released its final draft guidance recommending Itulazax® (Betula verrucosa)—the first sublingual (under the tongue) tablet immunotherapy, which could help up to 27,000 people in England with moderate to severe birch

Going on holiday is all about relaxing but for people with serious allergies, dining out in unfamiliar locations can bring added stress.

The UK medicines regulator (MHRA) has approved EURneffy®, the country’s first needle-free adrenaline nasal spray for the emergency treatment of serious allergic reactions (anaphylaxis) in adults and children weighing 30kg or more. This new option is expected to become available

For anyone living with food allergies—or caring for someone who does—the thought of experiencing a reaction at 30,000 feet can understandably trigger serious worry. People are well aware that help is far from being immediately available in the air, and

Anaphylaxis UK offers our condolences and heartfelt support to the family and friends of Benedict Blythe who was just five years old when he tragically died at school on 1st December 2021. 

Our forums focus on current challenges affecting the food industry in relation to allergens, including recent events, upcoming guidance, and industry challenges.

From 1st to 3rd July, Anaphylaxis UK carried out an impactful visit to the Isle of Man, delivering a series of tailored allergy awareness and training sessions to communities, schools, and healthcare professionals.  

As the weather warms up and we spend more time outdoors, it’s important to take steps to stay safe from insect stings—especially if you or someone you care for is allergic. The good news is that with a few simple precautions, you can still enjoy summer while reducing your risk of being stung.

Anaphylm is a medicine being developed by Aquestive Therapeutics for the emergency treatment of serious allergic reactions, including anaphylaxis.